CPA
HTGM
Cowen Prime Advisors’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-332,197
| Closed | -$462K | – | 183 |
|
|
2022
Q1 | $462K | Sell |
332,197
-260,936
| -44% | -$363K | 0.19% | 59 |
|
|
2021
Q4 | $3.22M | Sell |
593,133
-105,400
| -15% | -$571K | 1.09% | 23 |
|
|
2021
Q3 | $3.99M | Buy |
698,533
+128,200
| +22% | +$732K | 1.48% | 15 |
|
|
2021
Q2 | $3.31M | Buy |
570,333
+46,300
| +9% | +$269K | 1.2% | 20 |
|
|
2021
Q1 | $2.87M | Buy |
524,033
+82,115
| +19% | +$449K | 1.08% | 23 |
|
|
2020
Q4 | $2.12M | Sell |
441,918
-969,582
| -69% | -$4.64M | 0.94% | 24 |
|
|
2020
Q3 | $466K | Buy |
+1,411,500
| New | +$466K | 0.23% | 54 |
|
|
2020
Q2 | – | Sell |
-4,455,500
| Closed | -$1.45M | – | 218 |
|
|
2020
Q1 | $1.45M | Buy |
4,455,500
+2,317,600
| +108% | +$753K | 0.88% | 28 |
|
|
2019
Q4 | $1.5M | Buy |
2,137,900
+2,037,900
| +2,038% | +$1.43M | 0.69% | 35 |
|
|
2019
Q3 | $66K | Buy |
100,000
+90,000
| +900% | +$59.4K | 0.03% | 104 |
|
|
2019
Q2 | $17K | Sell |
10,000
-10,000
| -50% | -$17K | 0.01% | 143 |
|
|
2019
Q1 | $50K | Buy |
+20,000
| New | +$50K | 0.03% | 116 |
|